Table 4.
Model proportion needing treatment by age group and programme year, defining treatment need as proportion expected to die within 3 years in the absence of treatment
Years since start of treatment programme | ||||||
---|---|---|---|---|---|---|
Current age group | 0 | 1 | 2 | 3 | 4 | 5 |
15–19 | 0.091 | 0.112 | 0.124 | 0.131 | 0.134 | 0.135 |
20–24 | 0.153 | 0.196 | 0.230 | 0.258 | 0.282 | 0.300 |
25–29 | 0.203 | 0.259 | 0.306 | 0.347 | 0.383 | 0.414 |
30–34 | 0.245 | 0.309 | 0.364 | 0.413 | 0.456 | 0.493 |
35–39 | 0.282 | 0.353 | 0.415 | 0.469 | 0.517 | 0.558 |
40–44 | 0.315 | 0.392 | 0.459 | 0.517 | 0.568 | 0.612 |
45–49 | 0.344 | 0.427 | 0.498 | 0.559 | 0.611 | 0.656 |
50–54 | 0.371 | 0.459 | 0.533 | 0.595 | 0.648 | 0.694 |
55–59 | 0.396 | 0.487 | 0.563 | 0.627 | 0.680 | 0.725 |
60–64 | 0.419 | 0.513 | 0.591 | 0.655 | 0.709 | 0.753 |
65–69 | 0.441 | 0.538 | 0.616 | 0.681 | 0.734 | 0.777 |
70–74 | 0.461 | 0.560 | 0.639 | 0.704 | 0.756 | 0.799 |
75+ | 0.496 | 0.602 | 0.682 | 0.745 | 0.795 | 0.835 |
All age proportion given average HIV prevalence by age in ALPHA sites | ||||||
Males | 0.262 | 0.327 | 0.382 | 0.430 | 0.472 | 0.508 |
Females | 0.228 | 0.284 | 0.333 | 0.374 | 0.410 | 0.441 |
Both sexes | 0.240 | 0.299 | 0.350 | 0.394 | 0.432 | 0.465 |